Please login to the form below

Not currently logged in
Email:
Password:

ischaemic stroke

This page shows the latest ischaemic stroke news and features for those working in and with pharma, biotech and healthcare.

AZ says Brilinta hits the mark in diabetic heart disease

AZ says Brilinta hits the mark in diabetic heart disease

The study showed that in diabetics with CAD and no prior history of heart attack or stroke, Brilinta given on top of aspirin therapy achieved a statistically-significant reduction in a ... territory. Meanwhile, next year, AZ is also expecting a phase 3

Latest news

More from news
Approximately 1 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Deal Watch January 2016 Deal Watch January 2016

    therapy treatments including MultiStem for the treatment of ischaemic stroke.

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    225. Athersys / Chugai. Licence and collaboration Japan. Phase 2 stem cell therapy for treatment of ischaemic stroke.

  • The rise of chronic disease in BRIC markets The rise of chronic disease in BRIC markets

    Cardiovascular diseases – such as heart attack, stroke, DVT and atrial fibrillation – also present a major problem in Russia, with 46 per cent of self-reported sufferers (39 per cent being diagnosed). ... Analysts predict that ischaemic heart disease

  • e-Detailing options

    Boehringer Ingelheim, via Doctors.net.uk,  wished to provide an exceptional stroke resource for doctors. ... Doctors were therefore asked, at the start of the presentation, what they prescribed for patients following a first stroke or transient

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics